The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Glycopyrronium Market Research Report 2024
Synopsis
Glycopyrronium is used with other drugs to treat a certain type of stomach/intestinal ulcer (peptic ulcer). This medication may help relieve stomach/abdominal pain. However, it has not been shown to be effective in healing these ulcers, preventing them from returning, or preventing other problems caused by ulcers. Glycopyrronium works by decreasing the amount of acid in the stomach. It also slows the natural movements of the gut and relaxes the muscles in the stomach/intestines. Glycopyrronium belongs to a class of drugs known as anticholinergics.
The global Glycopyrronium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Glycopyrronium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glycopyrronium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glycopyrronium include Accord Healthcare, AstraZeneca, Merz Pharmaceuticals, Carwin Pharma, Sunovion Pharmaceuticals, Shionogi Inc, Novartis AG, Proveca Limited and Martindale Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glycopyrronium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycopyrronium.
Report Scope
The Glycopyrronium market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycopyrronium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycopyrronium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Accord Healthcare
AstraZeneca
Merz Pharmaceuticals
Carwin Pharma
Sunovion Pharmaceuticals
Shionogi Inc
Novartis AG
Proveca Limited
Martindale Pharma
Meitheal Pharmaceuticals
Segment by Type
Injection
Oral Solution
Tablet
Capsule
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glycopyrronium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glycopyrronium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Glycopyrronium is used with other drugs to treat a certain type of stomach/intestinal ulcer (peptic ulcer). This medication may help relieve stomach/abdominal pain. However, it has not been shown to be effective in healing these ulcers, preventing them from returning, or preventing other problems caused by ulcers. Glycopyrronium works by decreasing the amount of acid in the stomach. It also slows the natural movements of the gut and relaxes the muscles in the stomach/intestines. Glycopyrronium belongs to a class of drugs known as anticholinergics.
The global Glycopyrronium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Glycopyrronium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Glycopyrronium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Glycopyrronium include Accord Healthcare, AstraZeneca, Merz Pharmaceuticals, Carwin Pharma, Sunovion Pharmaceuticals, Shionogi Inc, Novartis AG, Proveca Limited and Martindale Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glycopyrronium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycopyrronium.
Report Scope
The Glycopyrronium market size, estimations, and forecasts are provided in terms of sales volume (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glycopyrronium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycopyrronium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Accord Healthcare
AstraZeneca
Merz Pharmaceuticals
Carwin Pharma
Sunovion Pharmaceuticals
Shionogi Inc
Novartis AG
Proveca Limited
Martindale Pharma
Meitheal Pharmaceuticals
Segment by Type
Injection
Oral Solution
Tablet
Capsule
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glycopyrronium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glycopyrronium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Glycopyrronium Market Overview
1.1 Product Overview and Scope of Glycopyrronium
1.2 Glycopyrronium Segment by Type
1.2.1 Global Glycopyrronium Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Oral Solution
1.2.4 Tablet
1.2.5 Capsule
1.3 Glycopyrronium Segment by Application
1.3.1 Global Glycopyrronium Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Glycopyrronium Market Size Estimates and Forecasts
1.4.1 Global Glycopyrronium Revenue 2019-2030
1.4.2 Global Glycopyrronium Sales 2019-2030
1.4.3 Global Glycopyrronium Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Glycopyrronium Market Competition by Manufacturers
2.1 Global Glycopyrronium Sales Market Share by Manufacturers (2019-2024)
2.2 Global Glycopyrronium Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Glycopyrronium Average Price by Manufacturers (2019-2024)
2.4 Global Glycopyrronium Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glycopyrronium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glycopyrronium, Product Type & Application
2.7 Glycopyrronium Market Competitive Situation and Trends
2.7.1 Glycopyrronium Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glycopyrronium Players Market Share by Revenue
2.7.3 Global Glycopyrronium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glycopyrronium Retrospective Market Scenario by Region
3.1 Global Glycopyrronium Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Glycopyrronium Global Glycopyrronium Sales by Region: 2019-2030
3.2.1 Global Glycopyrronium Sales by Region: 2019-2024
3.2.2 Global Glycopyrronium Sales by Region: 2025-2030
3.3 Global Glycopyrronium Global Glycopyrronium Revenue by Region: 2019-2030
3.3.1 Global Glycopyrronium Revenue by Region: 2019-2024
3.3.2 Global Glycopyrronium Revenue by Region: 2025-2030
3.4 North America Glycopyrronium Market Facts & Figures by Country
3.4.1 North America Glycopyrronium Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Glycopyrronium Sales by Country (2019-2030)
3.4.3 North America Glycopyrronium Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Glycopyrronium Market Facts & Figures by Country
3.5.1 Europe Glycopyrronium Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Glycopyrronium Sales by Country (2019-2030)
3.5.3 Europe Glycopyrronium Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glycopyrronium Market Facts & Figures by Country
3.6.1 Asia Pacific Glycopyrronium Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Glycopyrronium Sales by Country (2019-2030)
3.6.3 Asia Pacific Glycopyrronium Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Glycopyrronium Market Facts & Figures by Country
3.7.1 Latin America Glycopyrronium Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Glycopyrronium Sales by Country (2019-2030)
3.7.3 Latin America Glycopyrronium Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glycopyrronium Market Facts & Figures by Country
3.8.1 Middle East and Africa Glycopyrronium Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Glycopyrronium Sales by Country (2019-2030)
3.8.3 Middle East and Africa Glycopyrronium Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glycopyrronium Sales by Type (2019-2030)
4.1.1 Global Glycopyrronium Sales by Type (2019-2024)
4.1.2 Global Glycopyrronium Sales by Type (2025-2030)
4.1.3 Global Glycopyrronium Sales Market Share by Type (2019-2030)
4.2 Global Glycopyrronium Revenue by Type (2019-2030)
4.2.1 Global Glycopyrronium Revenue by Type (2019-2024)
4.2.2 Global Glycopyrronium Revenue by Type (2025-2030)
4.2.3 Global Glycopyrronium Revenue Market Share by Type (2019-2030)
4.3 Global Glycopyrronium Price by Type (2019-2030)
5 Segment by Application
5.1 Global Glycopyrronium Sales by Application (2019-2030)
5.1.1 Global Glycopyrronium Sales by Application (2019-2024)
5.1.2 Global Glycopyrronium Sales by Application (2025-2030)
5.1.3 Global Glycopyrronium Sales Market Share by Application (2019-2030)
5.2 Global Glycopyrronium Revenue by Application (2019-2030)
5.2.1 Global Glycopyrronium Revenue by Application (2019-2024)
5.2.2 Global Glycopyrronium Revenue by Application (2025-2030)
5.2.3 Global Glycopyrronium Revenue Market Share by Application (2019-2030)
5.3 Global Glycopyrronium Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Accord Healthcare
6.1.1 Accord Healthcare Corporation Information
6.1.2 Accord Healthcare Description and Business Overview
6.1.3 Accord Healthcare Glycopyrronium Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Accord Healthcare Glycopyrronium Product Portfolio
6.1.5 Accord Healthcare Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Glycopyrronium Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Glycopyrronium Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Merz Pharmaceuticals
6.3.1 Merz Pharmaceuticals Corporation Information
6.3.2 Merz Pharmaceuticals Description and Business Overview
6.3.3 Merz Pharmaceuticals Glycopyrronium Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merz Pharmaceuticals Glycopyrronium Product Portfolio
6.3.5 Merz Pharmaceuticals Recent Developments/Updates
6.4 Carwin Pharma
6.4.1 Carwin Pharma Corporation Information
6.4.2 Carwin Pharma Description and Business Overview
6.4.3 Carwin Pharma Glycopyrronium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Carwin Pharma Glycopyrronium Product Portfolio
6.4.5 Carwin Pharma Recent Developments/Updates
6.5 Sunovion Pharmaceuticals
6.5.1 Sunovion Pharmaceuticals Corporation Information
6.5.2 Sunovion Pharmaceuticals Description and Business Overview
6.5.3 Sunovion Pharmaceuticals Glycopyrronium Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sunovion Pharmaceuticals Glycopyrronium Product Portfolio
6.5.5 Sunovion Pharmaceuticals Recent Developments/Updates
6.6 Shionogi Inc
6.6.1 Shionogi Inc Corporation Information
6.6.2 Shionogi Inc Description and Business Overview
6.6.3 Shionogi Inc Glycopyrronium Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shionogi Inc Glycopyrronium Product Portfolio
6.6.5 Shionogi Inc Recent Developments/Updates
6.7 Novartis AG
6.6.1 Novartis AG Corporation Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Glycopyrronium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis AG Glycopyrronium Product Portfolio
6.7.5 Novartis AG Recent Developments/Updates
6.8 Proveca Limited
6.8.1 Proveca Limited Corporation Information
6.8.2 Proveca Limited Description and Business Overview
6.8.3 Proveca Limited Glycopyrronium Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Proveca Limited Glycopyrronium Product Portfolio
6.8.5 Proveca Limited Recent Developments/Updates
6.9 Martindale Pharma
6.9.1 Martindale Pharma Corporation Information
6.9.2 Martindale Pharma Description and Business Overview
6.9.3 Martindale Pharma Glycopyrronium Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Martindale Pharma Glycopyrronium Product Portfolio
6.9.5 Martindale Pharma Recent Developments/Updates
6.10 Meitheal Pharmaceuticals
6.10.1 Meitheal Pharmaceuticals Corporation Information
6.10.2 Meitheal Pharmaceuticals Description and Business Overview
6.10.3 Meitheal Pharmaceuticals Glycopyrronium Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Meitheal Pharmaceuticals Glycopyrronium Product Portfolio
6.10.5 Meitheal Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glycopyrronium Industry Chain Analysis
7.2 Glycopyrronium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glycopyrronium Production Mode & Process
7.4 Glycopyrronium Sales and Marketing
7.4.1 Glycopyrronium Sales Channels
7.4.2 Glycopyrronium Distributors
7.5 Glycopyrronium Customers
8 Glycopyrronium Market Dynamics
8.1 Glycopyrronium Industry Trends
8.2 Glycopyrronium Market Drivers
8.3 Glycopyrronium Market Challenges
8.4 Glycopyrronium Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Glycopyrronium Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Glycopyrronium Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Glycopyrronium Market Competitive Situation by Manufacturers in 2023
Table 4. Global Glycopyrronium Sales (Ton) of Key Manufacturers (2019-2024)
Table 5. Global Glycopyrronium Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Glycopyrronium Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Glycopyrronium Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Glycopyrronium Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Glycopyrronium, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Glycopyrronium, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Glycopyrronium, Product Type & Application
Table 12. Global Key Manufacturers of Glycopyrronium, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Glycopyrronium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycopyrronium as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Glycopyrronium Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Glycopyrronium Sales by Region (2019-2024) & (Ton)
Table 18. Global Glycopyrronium Sales Market Share by Region (2019-2024)
Table 19. Global Glycopyrronium Sales by Region (2025-2030) & (Ton)
Table 20. Global Glycopyrronium Sales Market Share by Region (2025-2030)
Table 21. Global Glycopyrronium Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Glycopyrronium Revenue Market Share by Region (2019-2024)
Table 23. Global Glycopyrronium Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Glycopyrronium Revenue Market Share by Region (2025-2030)
Table 25. North America Glycopyrronium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Glycopyrronium Sales by Country (2019-2024) & (Ton)
Table 27. North America Glycopyrronium Sales by Country (2025-2030) & (Ton)
Table 28. North America Glycopyrronium Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Glycopyrronium Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Glycopyrronium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Glycopyrronium Sales by Country (2019-2024) & (Ton)
Table 32. Europe Glycopyrronium Sales by Country (2025-2030) & (Ton)
Table 33. Europe Glycopyrronium Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Glycopyrronium Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Glycopyrronium Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Glycopyrronium Sales by Region (2019-2024) & (Ton)
Table 37. Asia Pacific Glycopyrronium Sales by Region (2025-2030) & (Ton)
Table 38. Asia Pacific Glycopyrronium Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Glycopyrronium Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Glycopyrronium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Glycopyrronium Sales by Country (2019-2024) & (Ton)
Table 42. Latin America Glycopyrronium Sales by Country (2025-2030) & (Ton)
Table 43. Latin America Glycopyrronium Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Glycopyrronium Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Glycopyrronium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Glycopyrronium Sales by Country (2019-2024) & (Ton)
Table 47. Middle East & Africa Glycopyrronium Sales by Country (2025-2030) & (Ton)
Table 48. Middle East & Africa Glycopyrronium Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Glycopyrronium Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Glycopyrronium Sales (Ton) by Type (2019-2024)
Table 51. Global Glycopyrronium Sales (Ton) by Type (2025-2030)
Table 52. Global Glycopyrronium Sales Market Share by Type (2019-2024)
Table 53. Global Glycopyrronium Sales Market Share by Type (2025-2030)
Table 54. Global Glycopyrronium Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Glycopyrronium Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Glycopyrronium Revenue Market Share by Type (2019-2024)
Table 57. Global Glycopyrronium Revenue Market Share by Type (2025-2030)
Table 58. Global Glycopyrronium Price (US$/Kg) by Type (2019-2024)
Table 59. Global Glycopyrronium Price (US$/Kg) by Type (2025-2030)
Table 60. Global Glycopyrronium Sales (Ton) by Application (2019-2024)
Table 61. Global Glycopyrronium Sales (Ton) by Application (2025-2030)
Table 62. Global Glycopyrronium Sales Market Share by Application (2019-2024)
Table 63. Global Glycopyrronium Sales Market Share by Application (2025-2030)
Table 64. Global Glycopyrronium Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Glycopyrronium Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Glycopyrronium Revenue Market Share by Application (2019-2024)
Table 67. Global Glycopyrronium Revenue Market Share by Application (2025-2030)
Table 68. Global Glycopyrronium Price (US$/Kg) by Application (2019-2024)
Table 69. Global Glycopyrronium Price (US$/Kg) by Application (2025-2030)
Table 70. Accord Healthcare Corporation Information
Table 71. Accord Healthcare Description and Business Overview
Table 72. Accord Healthcare Glycopyrronium Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. Accord Healthcare Glycopyrronium Product
Table 74. Accord Healthcare Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Glycopyrronium Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. AstraZeneca Glycopyrronium Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Merz Pharmaceuticals Corporation Information
Table 81. Merz Pharmaceuticals Description and Business Overview
Table 82. Merz Pharmaceuticals Glycopyrronium Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Merz Pharmaceuticals Glycopyrronium Product
Table 84. Merz Pharmaceuticals Recent Developments/Updates
Table 85. Carwin Pharma Corporation Information
Table 86. Carwin Pharma Description and Business Overview
Table 87. Carwin Pharma Glycopyrronium Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Carwin Pharma Glycopyrronium Product
Table 89. Carwin Pharma Recent Developments/Updates
Table 90. Sunovion Pharmaceuticals Corporation Information
Table 91. Sunovion Pharmaceuticals Description and Business Overview
Table 92. Sunovion Pharmaceuticals Glycopyrronium Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Sunovion Pharmaceuticals Glycopyrronium Product
Table 94. Sunovion Pharmaceuticals Recent Developments/Updates
Table 95. Shionogi Inc Corporation Information
Table 96. Shionogi Inc Description and Business Overview
Table 97. Shionogi Inc Glycopyrronium Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Shionogi Inc Glycopyrronium Product
Table 99. Shionogi Inc Recent Developments/Updates
Table 100. Novartis AG Corporation Information
Table 101. Novartis AG Description and Business Overview
Table 102. Novartis AG Glycopyrronium Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Novartis AG Glycopyrronium Product
Table 104. Novartis AG Recent Developments/Updates
Table 105. Proveca Limited Corporation Information
Table 106. Proveca Limited Description and Business Overview
Table 107. Proveca Limited Glycopyrronium Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Proveca Limited Glycopyrronium Product
Table 109. Proveca Limited Recent Developments/Updates
Table 110. Martindale Pharma Corporation Information
Table 111. Martindale Pharma Description and Business Overview
Table 112. Martindale Pharma Glycopyrronium Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Martindale Pharma Glycopyrronium Product
Table 114. Martindale Pharma Recent Developments/Updates
Table 115. Meitheal Pharmaceuticals Corporation Information
Table 116. Meitheal Pharmaceuticals Description and Business Overview
Table 117. Meitheal Pharmaceuticals Glycopyrronium Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. Meitheal Pharmaceuticals Glycopyrronium Product
Table 119. Meitheal Pharmaceuticals Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Glycopyrronium Distributors List
Table 123. Glycopyrronium Customers List
Table 124. Glycopyrronium Market Trends
Table 125. Glycopyrronium Market Drivers
Table 126. Glycopyrronium Market Challenges
Table 127. Glycopyrronium Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Glycopyrronium
Figure 2. Global Glycopyrronium Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Glycopyrronium Market Share by Type in 2023 & 2030
Figure 4. Injection Product Picture
Figure 5. Oral Solution Product Picture
Figure 6. Tablet Product Picture
Figure 7. Capsule Product Picture
Figure 8. Global Glycopyrronium Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Glycopyrronium Market Share by Application in 2023 & 2030
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Global Glycopyrronium Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Glycopyrronium Market Size (2019-2030) & (US$ Million)
Figure 14. Global Glycopyrronium Sales (2019-2030) & (Ton)
Figure 15. Global Glycopyrronium Average Price (US$/Kg) & (2019-2030)
Figure 16. Glycopyrronium Report Years Considered
Figure 17. Glycopyrronium Sales Share by Manufacturers in 2023
Figure 18. Global Glycopyrronium Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Glycopyrronium Players: Market Share by Revenue in 2023
Figure 20. Glycopyrronium Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Glycopyrronium Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Glycopyrronium Sales Market Share by Country (2019-2030)
Figure 23. North America Glycopyrronium Revenue Market Share by Country (2019-2030)
Figure 24. United States Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Glycopyrronium Sales Market Share by Country (2019-2030)
Figure 27. Europe Glycopyrronium Revenue Market Share by Country (2019-2030)
Figure 28. Germany Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Glycopyrronium Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Glycopyrronium Revenue Market Share by Region (2019-2030)
Figure 35. China Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Glycopyrronium Sales Market Share by Country (2019-2030)
Figure 45. Latin America Glycopyrronium Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Glycopyrronium Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Glycopyrronium Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Glycopyrronium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Glycopyrronium by Type (2019-2030)
Figure 55. Global Revenue Market Share of Glycopyrronium by Type (2019-2030)
Figure 56. Global Glycopyrronium Price (US$/Kg) by Type (2019-2030)
Figure 57. Global Sales Market Share of Glycopyrronium by Application (2019-2030)
Figure 58. Global Revenue Market Share of Glycopyrronium by Application (2019-2030)
Figure 59. Global Glycopyrronium Price (US$/Kg) by Application (2019-2030)
Figure 60. Glycopyrronium Value Chain
Figure 61. Glycopyrronium Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
